Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€50.50

€50.50

-0.980%
-0.5
-0.980%
€83.13
 
18.09.24 / Tradegate WKN: A1W1KK / Symbol: CYTK / Name: Cytokinetics / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Cytokinetics Inc. Stock

The price for the Cytokinetics Inc. stock decreased slightly today. Compared to yesterday there is a change of -€0.500 (-0.980%).
With 35 Buy predictions and 1 Sell predictions Cytokinetics Inc. is one of the favorites of our community.
With a target price of 83 € there is a hugely positive potential of 64.36% for Cytokinetics Inc. compared to the current price of 50.5 €.
So far the community has only identified positive things for Cytokinetics Inc. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".

Pros and Cons of Cytokinetics Inc. in the next few years

Pros
?
B****
?
M***** P*******
?
W********* I********* f** t** n*** y****
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Cytokinetics Inc. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Cytokinetics Inc. -0.980% 2.642% -1.942% 56.832% -33.987% 98.819% 328.184%
Evolus Inc -3.360% 5.109% 20.000% 68.421% 59.116% 114.925% -
Ardelyx Inc. -3.940% -1.625% 0.453% 36.215% -7.855% 371.327% 20.280%
Coherus Bioscien. 1.850% -20.402% -16.557% -77.568% -68.750% -93.667% -95.188%

Comments

Cytokinetics, Incorporated (NASDAQ: CYTK) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Ratings data for CYTK provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 1.00%
Target price 81.513
Change
Ends at 09.09.25

Cytokinetics, Incorporated (NASDAQ: CYTK) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $90.00 price target on the stock.
Ratings data for CYTK provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 0.00%
Target price 63.964
Change
Ends at 05.09.25

Cytokinetics, Incorporated (NASDAQ: CYTK) had its price target raised by analysts at JPMorgan Chase & Co. from $65.00 to $71.00. They now have an "overweight" rating on the stock.
Ratings data for CYTK provided by MarketBeat
Show more